Checkmate Pharmaceuticals
Checkmate Pharmaceuticals is a Cambridge, Massachusetts-based biopharmaceutical company focused on the activation of the innate immune system to treat cancer. The company was acquired by Regeneron in May 2022.
5
Funding Rounds
$229.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Pe*** Co******* | - | - | linkedin twitter instagram |
Funding
Funding series
Funding Series Analysis
The company Checkmate Pharmaceuticals has raised a total of $107m in funding over 5 rounds.
Key Insights:
- Checkmate Pharmaceuticals Series C round, June 2020: $85m
- Checkmate Pharmaceuticals , December 2018: $22m
- Checkmate Pharmaceuticals Series B round, June 2017: $27m
- Checkmate Pharmaceuticals, Inc. funding round, April 2020: $10m
- Checkmate Pharmaceuticals, Inc. Series C round, June 2020: $85m
Checkmate Pharmaceuticals Series C round, June 2020
$85m
Checkmate Pharmaceuticals , December 2018
$22m
Checkmate Pharmaceuticals, Inc. funding round, April 2020
$10m
Checkmate Pharmaceuticals Series B round, June 2017
$27m
Checkmate Pharmaceuticals, Inc. Series C round, June 2020
$85m
Industries
Checkmate Pharmaceuticals is active in the following industries: